High Affinity for Farnesyltransferase and Alternative Prenylation Contribute Individually to K-Ras4B Resistance to Farnesyltransferase Inhibitors
Open Access
- 1 October 2003
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (43) , 41718-41727
- https://doi.org/10.1074/jbc.m305733200
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Preclinical and clinical evaluation of farnesyltransferase inhibitors.Current Oncology Reports, 2003
- Farnesyltransferase inhibitors: promises and realitiesCurrent Opinion in Pharmacology, 2002
- Inhibitors of Protein Farnesyltransferase as Novel Anticancer AgentsCurrent Topics in Medicinal Chemistry, 2002
- Protein farnesylation in mammalian cells: effects of farnesyltransferase inhibitors on cancer cellsCellular and Molecular Life Sciences, 2001
- Farnesyltransferase inhibitors induce cytochrome c release and caspase 3 activation preferentially in transformed cellsProceedings of the National Academy of Sciences, 1998
- Farnesyltransferase inhibitors induce dramatic morphological changes of KNRK cells that are blocked by microtubule interfering agentsProceedings of the National Academy of Sciences, 1998
- Inhibition of the prenylation of K-Ras, but not H- or N-Ras, is highly resistant to CAAX peptidomimetics and requires both a farnesyltransferase and a geranylgeranyltransferase I inhibitor in human tumor cell linesOncogene, 1997
- Direct Demonstration of Geranylgeranylation and Farnesylation of Ki-Ras in VivoJournal of Biological Chemistry, 1997
- K- and N-Ras Are Geranylgeranylated in Cells Treated with Farnesyl Protein Transferase InhibitorsJournal of Biological Chemistry, 1997
- Protein PrenyltransferasesJournal of Biological Chemistry, 1996